Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant

Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant

The newly identified Omicron (B.1.1.529) variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has steered concerns across the world due to the possession of a large number of mutations leading to high infectivity and vaccine escape potential. The Omicron variant houses 32 mutation...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Format:	Artykuł
Język:	English
Wydane:	IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund 2022-03-01
Seria:	EXCLI Journal : Experimental and Clinical Sciences
Hasła przedmiotowe:	covid-19 sars-cov-2 variants omicron receptor binding domain human ace2
Dostęp online:	https://www.excli.de/index.php/excli/article/view/4721

Podobne zapisy

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
od: Mehdi Benlarbi, i wsp.
Wydane: (2024-08-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
od: Acharya Balkrishna, i wsp.
Wydane: (2025-02-01)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
od: Joseph Thomas Ortega, i wsp.
Wydane: (2021-12-01)

Omicron Spike Protein Has a Positive Electrostatic Surface That Promotes ACE2 Recognition and Antibody Escape
od: Hin Hark Gan, i wsp.
Wydane: (2022-06-01)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
od: Hao Yang, i wsp.
Wydane: (2022-06-01)

Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus
od: Koley T, i wsp.
Wydane: (2022-06-01)

Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
od: Angelin M. Philip, i wsp.
Wydane: (2023-01-01)

Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
od: Weitong Yao, i wsp.
Wydane: (2023-12-01)

SARS-CoV-2 omicron spike simulations: broad antibody escape, weakened ACE2 binding, and modest furin cleavage
od: M. Zaki Jawaid, i wsp.
Wydane: (2023-10-01)

Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
od: Mengjia Lu, i wsp.
Wydane: (2023-08-01)

A computational evaluation of structural stability of omicron and delta mutations of SARS-CoV-2 spike proteins and human ACE-2 interactions
od: Kehinde A. Idowu, i wsp.
Wydane: (2022-01-01)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
od: Jinkai Zang, i wsp.
Wydane: (2022-06-01)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
od: Riadh Badraoui, i wsp.
Wydane: (2021-01-01)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
od: Ruoke Wang, i wsp.
Wydane: (2022-06-01)

Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
od: Tove Hoffman, i wsp.
Wydane: (2023-05-01)

Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor
od: Nishad Sultana, i wsp.
Wydane: (2024-04-01)

Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages
od: Mukul Jain, i wsp.
Wydane: (2022-10-01)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
od: Arun Bahadur Gurung, i wsp.
Wydane: (2022-02-01)

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
od: Masaud Shah, i wsp.
Wydane: (2022-01-01)

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
od: Janhavi Prasad Natekar, i wsp.
Wydane: (2022-05-01)

ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity
od: Fedaa Ali, i wsp.
Wydane: (2020-12-01)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
od: Arun Bahadur Gurung, i wsp.
Wydane: (2021-02-01)

Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses (SARS‐CoV‐1 and SARS‐CoV‐2)
od: Agnieszka Rombel‐Bryzek, i wsp.
Wydane: (2023-01-01)

An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant
od: Haoran Zhang, i wsp.
Wydane: (2022-10-01)

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
od: Masaud Shah, i wsp.
Wydane: (2022-01-01)

Omicron Coronavirus: pH-Dependent Electrostatic Potential and Energy of Association of Spike Protein to ACE2 Receptor
od: Svetlana H. Hristova, i wsp.
Wydane: (2023-08-01)

Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
od: Wenhao Zhou, i wsp.
Wydane: (2022-02-01)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
od: Qianqian Li, i wsp.
Wydane: (2022-06-01)

Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity
od: Valeria Gerardi, i wsp.
Wydane: (2023-03-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
od: Abdullah Hoter, i wsp.
Wydane: (2022-05-01)

Insights from a computational analysis of the SARS‐CoV‐2 Omicron variant: Host–pathogen interaction, pathogenicity, and possible drug therapeutics
od: Md Sorwer Alam Parvez, i wsp.
Wydane: (2022-07-01)

Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant
od: Mengist HM, i wsp.
Wydane: (2022-07-01)

Studying the Effect of Glycosylation towards SARS-CoV-2 Spike RBD and ACE2 Interaction by Native Mass Spectrometry
od: LUO Yu-xiang;HUANG Jing;LI Hui-lin
Wydane: (2022-11-01)

Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
od: Nuchjira Takheaw, i wsp.
Wydane: (2022-05-01)

Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
od: Jian-Piao Cai, i wsp.
Wydane: (2023-03-01)

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor
od: Alamgir Khan, i wsp.
Wydane: (2022-06-01)

АНАЛИЗ ВЛИЯНИЯ МУТАЦИЙ НА АФФИННОСТЬ СВЯЗЫВАНИЯ В КОМПЛЕКСАХ ACE2 И RBD S-БЕЛКА КОРОНАВИРУСОВ
od: Богданова Е.А., i wsp.
Wydane: (2023-11-01)

Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin‐converting enzyme 2
od: Kyungmin Lee, i wsp.
Wydane: (2024-04-01)

Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
od: Abdulrahim R. Hakami
Wydane: (2022-02-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
od: Marcus Ho-Hin Shum, i wsp.
Wydane: (2024-12-01)